Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, September 2004, p. 3279-3283, Vol. 48, No. 9
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.9.3279-3283.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
In Vitro Activity of Caspofungin Combined with Sulfamethoxazole against Clinical Isolates of Aspergillus spp.
Aya Yekutiel,1 Itamar Shalit,1,2 Yona Shadkchan,1 and Nir Osherov1*Sackler School of Medicine, Tel-Aviv University, Tel-Aviv,1 Schneider Children's Medical Center of Israel, Petach Tikvah, Israel2
Received 18 February 2004/ Returned for modification 15 March 2004/ Accepted 3 May 2004
Caspofungin (CAS) inhibits fungal cell wall synthesis. Sulfamethoxazole (SMX) inhibits folate biosynthesis and is active in vitro against Aspergillus spp. We studied the activities of the combination of CAS and SMX against 31 Aspergillus isolates and compared them with that of SMX combined with amphotericin B (AMB) or itraconazole (ITC). MICs and minimal effective concentrations (MECs) were determined by the NCCLS broth microdilution method. With MIC endpoints, the combination of SMX and CAS showed synergy or synergy to additivity against 29 of 31 isolates. With MEC endpoints, synergy to additivity was found against 12 of 31 isolates and indifference was displayed against the rest of them. SMX in combination with AMB or ITC was not truly synergistic, while synergy to additivity was found for SMX-AMB and SMX-ITC against 17 of 31 and 3 of 12 isolates, respectively. No antagonism was found with any of the drug combinations. Further analysis of the synergy of CAS and SMX was performed by detailed measurement of hyphal length by microscopy and time-dependent 2,3-bis(2-methoxy-4-nitro-5-[(sulfenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT)-based hyphal damage experiments. With MEC endpoints, the combination of CAS and SMX was characterized by a greater than 50% decrease in hyphal length compared to the hyphal lengths achieved with double the concentration of each drug alone. The XTT-based hyphal damage studies showed a statistically significant (P < 0.05) reduction in viability with CAS and SMX in combination compared to the viabilities achieved with double the concentration of each drug alone. These findings support the synergy results found by using MIC endpoints and suggest that visual MEC measurements may not be sufficient to identify the synergistic interactions seen by more sensitive, quantitative methods. Animal models are required to validate the significance of the synergy of CAS and SMX against Aspergillus spp. observed in vitro.
* Corresponding author. Mailing address: Department of Human Microbiology, Sackler School of Medicine, Tel-Aviv University, Ramat-Aviv 69978, Tel-Aviv, Israel. Phone: 972-3-640-9599. Fax: 972-3-640-9160. E-mail: nosherov{at}post.tau.ac.il.
Antimicrobial Agents and Chemotherapy, September 2004, p. 3279-3283, Vol. 48, No. 9
0066-4804/04/$08.00+0 DOI: 10.1128/AAC.48.9.3279-3283.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Antachopoulos, C., Meletiadis, J., Sein, T., Roilides, E., Walsh, T. J.
(2007). Concentration-Dependent Effects of Caspofungin on the Metabolic Activity of Aspergillus Species. Antimicrob. Agents Chemother.
51: 881-887
[Abstract] [Full Text] -
Shalit, I., Halperin, D., Haite, D., Levitov, A., Romano, J., Osherov, N., Fabian, I.
(2006). Anti-inflammatory effects of moxifloxacin on IL-8, IL-1{beta} and TNF-{alpha} secretion and NF{kappa}B and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatus. J Antimicrob Chemother
57: 230-235
[Abstract] [Full Text]
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»